OpenHouse procedure for various pharmaceutical active substances from 01.10.2026
AOK Rheinland/Hamburg - Die Gesundheitskasse, DüsseldorfTED 367164-2026
value not stated1 lot, 2 years
Sun 31 Dec12:00 in Berlin
794days
Public tenders in Germany
725 open tenders
CountryTenderValueClosesDays left
Conclusion of a non-exclusive discount agreement pursuant to § 130a, paragraph 8 of the Social Code Book V (SGB V) for Ezetimibe + Atorvastatin (excluding pack size 90 pieces) for the period 01.03.2026 - 29.02.2028 (including V-option 1x12 months)
DAK-Gesundheit, HamburgTED 35353-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Estradiol + Dienogest, ATC code G03AB08 for the period from 01.03.2026 to 29.02.2028 (including extension option of 1x12 months)
DAK-Gesundheit, HamburgTED 35539-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Metronidazole, ATC D06BX01, for the period 01.03.2026 - 29.02.2028 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 30981-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Code Book V (SGB V) for the active substance Meropenem, ATC code J01DH02, for the period from 01.03.2026 to 29.02.2028 (including extension option of 1x12 months)
DAK-Gesundheit, HamburgTED 34167-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Isosorbide mononitrate, ATC C01DA14, for the period 01.03.2026 - 29.02.2028 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 33175-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Pegfilgrastim, ATC L03AA13, for the period 01.03.2026 – 29.02.2028 (plus extension option 1 × 12 months)
DAK-Gesundheit, HamburgTED 34425-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Liraglutid, ATC A10BJ02 for the period 01.03.2026 - 29.02.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 38439-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Potassium iodide, ATC H03CA01, for the period 01.03.2026 - 29.02.2028 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 33270-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Budesonide, ATC A07EA06, for the period 01.03.2026 - 29.02.2028 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 34124-2026
€11 lot, 2 years
Fri 5 Jan12:00 in Berlin
799days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active ingredient Betamethasone + Gentamicin, ATC D07CC01 for the period 01.04.26 - 31.03.28 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 111120-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Estriol (excluding Dafo. VCR), ATC G03CD01, for the period 01.04.26 – 31.03.28 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 113873-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Lercanidipin, ATC C08CA13, for the period 01.04.2026 – 31.03.2028 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 113900-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Pyridoxine, ATC M03BX03, for the period 01.04.2026 - 31.03.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 113579-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Filgrastim, ATC L03AA02, for the period 01.04.2026 - 31.03.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 112662-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Tranylcypromin, ATC N06AF04, for the period 01.04.2026 - 31.03.2028 (plus extension option of 1x12 months)
DAK-Gesundheit, HamburgTED 111445-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active ingredient Dexamethasone + Gentamicin, ATC S01CA21 for the period 01.04.2026 - 31.03.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 111258-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active ingredient Ipratropium (excluding Dafo. LOV), ATC R03BB01 for the period 01.04.26 - 31.03.28 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 111297-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Sultamicillin, ATC J01CR04, for the period 01.04.2026 - 31.03.2028 (plus extension option of 1x12 months)
DAK-Gesundheit, HamburgTED 111816-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Caspofungin, ATC J02AX04, for the period 01.04.2026 - 31.03.2028 (plus extension option of 1x12 months)
DAK-Gesundheit, HamburgTED 111473-2026
€11 lot, 2 years
Mon 5 Feb12:00 in Berlin
830days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.